These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 33847998)

  • 21. Retrospective hospital-based analysis of age-related macular degeneration patterns in India: 5-year follow-up.
    Sudhalkar A; Sethi V; Gogte P; Bondalapati S; Khodani M; Chhablani JK
    Indian J Ophthalmol; 2015 Dec; 63(12):899-904. PubMed ID: 26862094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Inflammation in Age-Related Macular Degeneration-Therapeutic Landscapes in Geographic Atrophy.
    Borchert GA; Shamsnajafabadi H; Hu ML; De Silva SR; Downes SM; MacLaren RE; Xue K; Cehajic-Kapetanovic J
    Cells; 2023 Aug; 12(16):. PubMed ID: 37626902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fellow Eye Comparisons for 7-Year Outcomes in Ranibizumab-Treated AMD Subjects from ANCHOR, MARINA, and HORIZON (SEVEN-UP Study).
    Bhisitkul RB; Desai SJ; Boyer DS; Sadda SR; Zhang K
    Ophthalmology; 2016 Jun; 123(6):1269-77. PubMed ID: 26996339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atrophy of the macula in the context of its wet, age-related degeneration : An inescapable consequence of anti-VEGF therapy?].
    Garweg JG
    Ophthalmologe; 2016 Dec; 113(12):1036-1045. PubMed ID: 27364637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
    Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation studies of ranibizumab for neovascular age-related macular degeneration.
    Bloch SB
    Acta Ophthalmol; 2013 Nov; 91 Thesis7():1-22. PubMed ID: 24206851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.
    Nagiel A; Freund KB; Spaide RF; Munch IC; Larsen M; Sarraf D
    Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Subhi Y; Krogh Nielsen M; Molbech CR; Krüger Falk M; Singh A; Hviid TVF; Nissen MH; Sørensen TL
    JAMA Ophthalmol; 2019 May; 137(5):515-522. PubMed ID: 30844038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.
    Nassisi M; Lei J; Abdelfattah NS; Karamat A; Balasubramanian S; Fan W; Uji A; Marion KM; Baker K; Huang X; Morgenthien E; Sadda SR
    Ophthalmology; 2019 Dec; 126(12):1667-1674. PubMed ID: 31281056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Choroidal cleft simulating choroidal caverns in neovascular age-related macular degeneration.
    Pece A; Borrelli E; Sacconi R; Maione G; Bandello F; Querques G
    Eur J Ophthalmol; 2019 Sep; 29(5):471-473. PubMed ID: 31353948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration.
    Spraul CW; Grossniklaus HE
    Arch Ophthalmol; 1997 Feb; 115(2):267-73. PubMed ID: 9046265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Xu L; Mrejen S; Jung JJ; Gallego-Pinazo R; Thompson D; Marsiglia M; Freund KB
    Retina; 2015 Feb; 35(2):176-86. PubMed ID: 25387047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of autologous transplantation of retinal pigment epithelium (RPE) monolayer sheet graft with RPE-Bruch's membrane complex graft in neovascular age-related macular degeneration.
    Lu Y; Han L; Wang C; Dou H; Feng X; Hu Y; Feng K; Wang X; Ma Z
    Acta Ophthalmol; 2017 Sep; 95(6):e443-e452. PubMed ID: 27496526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Neovascular Age-related Macular Degeneration: A Review on Landmark Randomized Controlled Trials.
    Agarwal A; Aggarwal K; Gupta V
    Middle East Afr J Ophthalmol; 2016; 23(1):27-37. PubMed ID: 26957836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
    Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
    Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
    Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
    JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of age-related macular degeneration.
    Young RW
    Surv Ophthalmol; 1987; 31(5):291-306. PubMed ID: 3299827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related macular degeneration (AMD): pathogenesis and therapy.
    Nowak JZ
    Pharmacol Rep; 2006; 58(3):353-63. PubMed ID: 16845209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents.
    Gemenetzi M; Lotery AJ; Patel PJ
    Eye (Lond); 2017 Jan; 31(1):1-9. PubMed ID: 27716750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectral profiling of autofluorescence associated with lipofuscin, Bruch's Membrane, and sub-RPE deposits in normal and AMD eyes.
    Marmorstein AD; Marmorstein LY; Sakaguchi H; Hollyfield JG
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2435-41. PubMed ID: 12091448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.